SARS News and Research

RSS

Exploring mutational energetics and the role of arginine blockers in COVID-19 treatments

A new study aimed to describe the roles of certain specific mutations in SARS-CoV-2 strains, with respect to their ability to conformationally stabilize S-protein structure resulting in enhanced receptor-binding domain ACE2 binding.

17 May 2022

Researchers explore broad-based immunity against potentially pandemic-causing viruses

A new study focused on broad-spectrum immunity against viruses that harbor the potential for generating a pandemic involving humans, especially those with the potential for zoonotic spillover.

17 May 2022

Researchers develop treatment that suppresses mutational escape of SARS-CoV-2

Researchers from Xiamen University have created a new treatment that is less likely to be affected by mutations in the receptor-binding domain of SARS-CoV-2.

17 May 2022

Hormone replacement therapy associated with reduction in mortality from COVID-19

A new paper in Family Practice, published by Oxford University Press, indicates that receiving hormone replacement therapy within six months of a recorded diagnosis of COVID-19 was associated with a reduction in mortality from the disease.

17 May 2022

Researchers explore COVID-19 vaccination in immunocompromised individuals

A new study discusses the safety and efficacy of the COVID-19 vaccination and potential strategies to optimize protection in patients with impaired immunity.

17 May 2022

Neutralization of SARS-CoV-2 by plant-made neutralizing monoclonal antibodies

In a recent study published in the journal Vaccines, researchers developed plant-based monoclonal antibodies (mAbs) against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).

17 May 2022

A study of SARS-CoV-2-mRNA booster vaccinations in immunocompromised patients

In a recent study published in the journal Frontiers in Immunology, researchers assessed the immune responses induced by vaccination with the messenger ribonucleic acid (mRNA)-1273 vaccine or the BNT162b2 vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections among immunocompromised individuals.

17 May 2022

Broad-spectrum polymeric antivirals against SARS-CoV-2

In a recent study published in the journal Advanced Science, researchers evaluated the potential and applicability of macromolecular viral inhibitors against respiratory viral pathogens.

17 May 2022

Factors impacting anti-SARS-CoV-2 antibodies in healthcare personnel

In a recent study posted to the medRxiv* preprint server, researchers assessed variables that influence anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody titers in medical professionals.

16 May 2022

Evaluating SARS-CoV-2 infection risk in indoor environments

In a recent study posted to the Research Square* preprint server, researchers evaluated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection risk for indoor scenarios.

16 May 2022

Why do diabetic patients have more severe SARS-CoV-2 infections?

A recent study published in the journal Cell Metabolism illustrated the function of angiotensin-converting enzyme 2 (ACE2) in renal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among diabetic patients.

16 May 2022

Characterizing SARS-CoV-2 non-structural protein 15 endoribonuclease variants

In a recent study posted to the bioRxiv* pre-print server, researchers characterized the mutations in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) non-structural protein 15 (Nsp-15).

16 May 2022

Scientists use machine learning techniques for better characterization of long COVID

A research team supported by the National Institutes of Health has identified characteristics of people with long COVID and those likely to have it.

16 May 2022

Death or readmission after discharge from COVID-19 hospitalization is common, study finds

For patients discharged after hospitalization for COVID-19, death or readmission was common, with about 11% being readmitted or dying within 30 days, according to new research published in CMAJ.

16 May 2022

Triple vaccination found to confer immune protection against SARS-CoV-2 Omicron BA.2 sublineage

Researchers assessed the immune responses induced by two doses or three doses of the BNT162b2 (BNT) or the CoronaVac (CorV) vaccine against SARS-CoV-2 Omicron BA.2 sublineage among public servants working for the government of Hong Kong.

16 May 2022

Unique antibody responses after third COVID-19 mRNA vaccination

Researchers observed that a third messenger ribonucleic acid COVID-19 vaccine elicits a unique antibody response.

16 May 2022

Early impact of SARS-CoV-2 on human lungs

In a new study, researchers assessed the impact of coronavirus disease 2019 (COVID-19) on human lung cells.

16 May 2022

Evolution of SARS-CoV-2 variants of concern

Researchers investigated the evolution of different SARS-CoV-2 variants of concern.

16 May 2022

SARS-CoV-2 Omicron BA.2 differs antigenically from previous variants

Researchers observed that the SARS-CoV-2 Omicron BA.2 variant is immunologically different from other variants, including Omicron BA.1.

16 May 2022

Exploring age-associated differences in T lymphocyte immune responses after BNT162b2 vaccination

Researchers compared the immunogenicity of or and reactogenicity to the BNT162b2 vaccine in Japanese adults and elders.

16 May 2022

SARS News and Research

Exploring mutational energetics and the role of arginine blockers in COVID-19 treatments

Researchers explore broad-based immunity against potentially pandemic-causing viruses

Researchers develop treatment that suppresses mutational escape of SARS-CoV-2

Hormone replacement therapy associated with reduction in mortality from COVID-19

Researchers explore COVID-19 vaccination in immunocompromised individuals

Neutralization of SARS-CoV-2 by plant-made neutralizing monoclonal antibodies

A study of SARS-CoV-2-mRNA booster vaccinations in immunocompromised patients

Broad-spectrum polymeric antivirals against SARS-CoV-2

Factors impacting anti-SARS-CoV-2 antibodies in healthcare personnel

Evaluating SARS-CoV-2 infection risk in indoor environments

Why do diabetic patients have more severe SARS-CoV-2 infections?

Characterizing SARS-CoV-2 non-structural protein 15 endoribonuclease variants

Scientists use machine learning techniques for better characterization of long COVID

Death or readmission after discharge from COVID-19 hospitalization is common, study finds

Triple vaccination found to confer immune protection against SARS-CoV-2 Omicron BA.2 sublineage

Unique antibody responses after third COVID-19 mRNA vaccination

Early impact of SARS-CoV-2 on human lungs

Evolution of SARS-CoV-2 variants of concern

SARS-CoV-2 Omicron BA.2 differs antigenically from previous variants

Exploring age-associated differences in T lymphocyte immune responses after BNT162b2 vaccination

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News